Epicardial adipose tissue and subclinical incident atrial fibrillation as detected by continuous monitoring: a cardiac magnetic resonance imaging study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,15 MB, PDF-dokument

Epicardial adipose tissue (EAT) has endocrine and paracrine functions and has been associated with metabolic and cardiovascular disease. This study aimed to investigate the association between EAT, determined by cardiac magnetic resonance imaging (CMR), and incident atrial fibrillation (AF) following long-term continuous heart rhythm monitoring by implantable loop recorder (ILR). This study is a sub-study of the LOOP study. In total, 203 participants without a history of AF received an ILR and underwent advanced CMR. All participants were at least 70 years of age at inclusion and had at least one of the following conditions: hypertension, diabetes, previous stroke, or heart failure. Volumetric measurements of atrial- and ventricular EAT were derived from CMR and the time to incident AF was subsequently determined. A total of 78 participants (38%) were diagnosed with subclinical AF during a median of 40 (37–42) months of continuous monitoring. In multivariable Cox regression analyses adjusted for age, sex, and various comorbidities, we found EAT indexed to body surface area to be independently associated with the time to AF with hazard ratios (95% confidence intervals) up to 2.93 (1.36–6.34); p = 0.01 when analyzing the risk of new-onset AF episodes lasting ≥ 24 h. Atrial EAT assessed by volumetric measurements on CMR images was significantly associated with the incident AF episodes as detected by ILR.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cardiovascular Imaging
Vol/bind40
Sider (fra-til) 591–599
ISSN1569-5794
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
Open access funding provided by National Hospital. EG is funded by a scholarship grant from the Novo Nordisk Foundation Denmark. The sponsor had no role in the study design, data collection, data analysis, or data interpretation. The LOOP Study is supported by Innovation Fund Denmark (12-135225), The Research Foundation for the Capital Region of Denmark, The Danish Heart Foundation (11-04-R83-A3363-22625), Aalborg University Talent Management Program, Arvid Nilssons Fond, Skibsreder Per Henriksen, R og Hustrus Fond, The AFFECT-EU Consortium (Horizon 2020, Grant Number 847770-AFFECT-EU), Læge Sophus Carl Emil Friis og hustru Olga Doris Friis’ Legat, and an unrestricted grant from Medtronic. We thank Dan Atar (University of Oslo and Department of Cardiology B, Oslo University Hospital Ullevål, Oslo, Norway), and Mårten Rosenqvist (Karolinska Institutet and Danderyd Hospital, Stockholm, Sweden), for assisting the study with their expertise in the study’s international advisory committee.

Publisher Copyright:
© 2024, The Author(s).

ID: 380658194